| Date Filed | Type | Description |
| 03/09/2023 |
4
| KELLOGG PETER N (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 4,948 options to buy
@ $194.34, valued at
$961.6k
|
|
| 03/09/2023 |
3
| KELLOGG PETER N (Director) has filed a Form 3 on ALNYLAM PHARMACEUTICALS, INC. |
| 05/23/2019 |
4
| KELLOGG PETER N (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 10,000 options to buy
@ $0.9, valued at
$9k
|
|
| 01/03/2019 |
4
| KELLOGG PETER N (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 6,128 options to buy
@ $0.83, valued at
$5.1k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2018 |
4
| KELLOGG PETER N (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 3,583 options to buy
@ $1.41, valued at
$5.1k
|
|
| 05/25/2018 |
4
| KELLOGG PETER N (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 10,000 options to buy
@ $1.65, valued at
$16.5k
|
|
| 05/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2018 |
4
| KELLOGG PETER N (SEE REMARKS) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Paid exercise price by delivering 1,622 shares
@ $86.89, valued at
$140.9k
Exercised 3,500 restricted stock units
@ $0 |
|
| 04/02/2018 |
4
| KELLOGG PETER N (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 2,958 options to buy
@ $1.95, valued at
$5.8k
|
|
| 02/20/2018 |
4
| KELLOGG PETER N (See Remarks) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Paid exercise price by delivering 2,329 shares
@ $95.26, valued at
$221.9k
Exercised 7,283 rights
@ $0 |
|
| 02/15/2018 |
4
| KELLOGG PETER N (See Remarks) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 7,283 rights
@ $0 |
|
| 01/31/2018 |
4
| KELLOGG PETER N (See Remarks) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 13,377 options to buy
@ $103.26, valued at
$1.4M
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2017 |
4
| KELLOGG PETER N (See Remarks) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Paid exercise price by delivering 1,768 shares
@ $107.06, valued at
$189.3k
Exercised 3,410 restricted stock units
@ $0 |
|
| 11/30/2017 |
4
| KELLOGG PETER N (Director) has filed a Form 4 on YIELD10 BIOSCIENCE, INC.|
Txns:
| Granted 5,258 options to buy
@ $2.34, valued at
$12.3k
|
|
| 10/31/2017 |
4
| KELLOGG PETER N (See Remarks) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Paid exercise price by delivering 1,088 shares
@ $98.17, valued at
$106.8k
Exercised 2,100 restricted stock units
@ $0
Granted 30,911 options to buy
@ $100.97, valued at
$3.1M
Granted 3,666 restricted stock units
@ $0 |
|
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/02/2016 |
4
| KELLOGG PETER N (See Remarks) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 32,104 options to buy
@ $102.18, valued at
$3.3M
Granted 5,609 restricted stock units
@ $0 |
|
| 05/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/28/2016 |
4
| KELLOGG PETER N (See Remarks) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Granted 8,625 options to buy
@ $109.9, valued at
$947.9k
Granted 3,500 restricted stock units
@ $0 |
|
| 06/10/2013 |
4
| KELLOGG PETER N (Director) has filed a Form 4 on METABOLIX, INC.|
Txns:
| Granted 10,000 options
@ $1.55, valued at
$15.5k
|
|
| 05/08/2013 |
4
| KELLOGG PETER N (Exe V-P & CFO) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Exercised 37,325 shares
@ $0
Paid exercise price by delivering 19,354 shares
@ $44.98, valued at
$870.5k
Granted 206,119 options to buy
@ $44.98, valued at
$9.3M
Exercised 37,325 restricted stock units
@ $44.98, valued at
$1.7M
|
|
| 02/27/2013 |
4
| KELLOGG PETER N (Exe V-P & CFO) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Granted 17,178 shares
@ $42.52, valued at
$730.4k
|
|
| 06/11/2012 |
4
| KELLOGG PETER N (Director) has filed a Form 4 on METABOLIX, INC.|
Txns:
| Granted 10,000 options
@ $2.16, valued at
$21.6k
|
|
| 05/04/2012 |
4
| KELLOGG PETER N (Exe V-P & CFO) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Granted 16,289 restricted stock units
@ $0
Granted 234,004 options to buy
@ $39.29, valued at
$9.2M
|
|
| 04/26/2012 |
4
| KELLOGG PETER N (Exe V-P & CFO) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Exercised 17,550 shares
@ $0
Paid exercise price by delivering 8,135 shares
@ $38.27, valued at
$311.3k
Exercised 17,550 restricted stock units
@ $38.27, valued at
$671.6k
|
|
| 03/01/2012 |
4
| KELLOGG PETER N (Exe V-P & CFO) has filed a Form 4 on Merck & Co. Inc.|
Txns:
| Granted 13,069 shares
@ $38.38, valued at
$501.6k
|
|
| 05/31/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|